BI, K., HK, T., N, S., JV, A., VT, P., N, S., . . . P, S. (2026). Botulinum toxin for endometriosis-associated chronic pelvic pain: A randomised, double-masked, parallel, phase 2 trial. EClinicalMedicine, 91, 103740. https://doi.org/10.1016/j.eclinm.2025.103740
Chicago Style (17th ed.) CitationBI, Karp, Tandon HK, Sinaii N, Aredo JV, Phan VT, Salmeri N, Shah JP, Merideth MA, and Stratton P. "Botulinum Toxin for Endometriosis-associated Chronic Pelvic Pain: A Randomised, Double-masked, Parallel, Phase 2 Trial." EClinicalMedicine 91 (2026): 103740. https://doi.org/10.1016/j.eclinm.2025.103740.
MLA (9th ed.) CitationBI, Karp, et al. "Botulinum Toxin for Endometriosis-associated Chronic Pelvic Pain: A Randomised, Double-masked, Parallel, Phase 2 Trial." EClinicalMedicine, vol. 91, 2026, p. 103740, https://doi.org/10.1016/j.eclinm.2025.103740.